Lion Biotechnologies Inc

(GNBPD)

By |

Profile

Iovance Biotherapeutics Inc operates in the healthcare sector based in the United States. It is a pharmaceutical manufacturer attending to serious diseases such as cancer. The Company's lead pipeline candidate, LN-144, is an adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) to treat patients with refractory metastatic melanoma. The TIL therapy involves growing a patient's special culture conditions outside the patient's body, or ex vivo, and then infusing the T cells back into the patient.

Contact Information

Website: www.iovance.com
Email: sarah@sternir.com
Main Phone: +1 650 260-7120
Address: 999 Skyway Road
Address 2: Suite 150
State: CA
City / Town: San Carlos
Country: USA
Postal Code: 94070

Issuer Information

Exchange: OTO
CEO: Maria Fardis
Employees: 63
NAICS: Medicinal and Botanical Manufacturing(325411)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 123,169,528.00 EPS (TTM) -1.36 PE Ratio N/A Exchange OTCPK
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 18 18 18 18
Low Target Price Estimate 13 13 13 13
Mean Target Price Estimate 15.4 15.4 15.4 15.4
Standard Deviation 1.82 1.82 1.82 1.82
Date of Most Recent Estimate 07/08/16 07/08/16 07/08/16 07/08/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1